Pfizer (Switzerland)

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri et al. · The Lancet Oncology · 2021 · 582 citations

Neoadjuvant Therapy, Squamous Cell Carcinoma, Medicine +8

Enteric coated HPMC capsules designed to achieve intestinal targeting

Ewart T. Cole, Robert A. Scott, Alyson Connor et al. · International Journal of Pharmaceutics · 2002 · 236 citations

Gut Barrier, Gastroenterology, Biomedical Engineering +1

Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent

Paolo Ferrari, P Weidmann, Sidney Shaw et al. · The American Journal of Medicine · 1991 · 205 citations

Obesity, Nutrition, Hypertension +11

In Vitro and in Vivo Pharmacoscintigraphic Evaluation of Ibuprofen Hypromellose and Gelatin Capsules

Ewart T. Cole, Robert A. Scott, Dominique Cadé et al. · Pharmaceutical Research · 2004 · 62 citations

Pharmaceutical Science, Vivo Pharmacoscintigraphic Evaluation, Medicine +7

910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

Ezra E.W. Cohen, Robert L. Ferris, Amanda Psyrri et al. · Annals of Oncology · 2020 · 40 citations · Full text